IL5 and Alzheimer disease: Furthermore, the immunological results—particularly the suppression of IL-4, IL-5, IL-13, TSLP, and IgE—indicate that KYN effectively mitigates the Th2-skewed immune response, which is a hallmark of AD pathophysiology.